Don't let NASH be your silent partner.

The NATiV3 Study is now enrolling.

NASH (non-alcoholic steatohepatitis) is the result of fat buildup and inflammation in the liver, which can cause serious health hazards. If you have been diagnosed with NASH or liver fibrosis, you may be eligible to participate in a clinical study evaluating an investigational treatment.

To see if the NATiV3 Study is right for you, please contact us.

Location: MNGI Digestive Health, Northeast Minneapolis Clinic

Physician Investigator: Dr. Hanouneh

Study Coordinator: Naomi Mugarura

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.